Biocryst Pharmaceuticals Inc (BCRX)

09:05 AM

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Astria Therapeutics, Inc. (NASDAQ: ATXS) - WV News

09:05 AM

05:22 AM

Oppenheimer downgrades Astria Therapeutics stock rating to Perform on BioCryst acquisition - Investing.com UK

05:22 AM

04:44 AM

Low frequency sounds good to Biocryst in $700M Astria HAE buy - BioWorld MedTech

04:44 AM

04:36 AM

BioCryst stock price target raised to $15 by RBC on HAE acquisition - Investing.com UK

04:36 AM

04:30 AM

BioCryst Pharma stock price target raised to $15 by Jefferies on Astria acquisition - Investing.com Canada

04:30 AM

04:00 AM

What technical models suggest about BioCryst Pharmaceuticals Inc.’s comeback2025 Growth vs Value & Smart Allocation Stock Reports - newser.com

04:00 AM

03:59 AM

Is BioCryst Pharmaceuticals Inc. stock bottoming outWall Street Watch & Risk Managed Trade Strategies - newser.com

03:59 AM

03:43 AM

Will BioCryst Pharmaceuticals Inc. stock maintain growth storyJuly 2025 Big Picture & Free Long-Term Investment Growth Plans - newser.com

03:43 AM

02:57 AM

Has BioCryst Pharmaceuticals Inc. formed a bullish divergence2025 Dividend Review & Scalable Portfolio Growth Ideas - newser.com

02:57 AM

02:50 AM

Biocryst Pharmaceuticals stock hits 52-week low at $6.00 By Investing.com - Investing.com South Africa

02:50 AM

01:48 AM

BioCryst to Acquire Astria in $700M Deal - USA Herald

01:48 AM

01:17 AM

Covington, Sidley Guide $700M BioCryst Allergic Disease Deal - Law360

01:17 AM

12:20 PM

BioCryst Says Astria Therapeutics $700 Million Deal Gives 'Perfect Second Product Candidate' - Benzinga

12:20 PM

11:50 AM

BioCryst Pharmaceuticals, Inc. agreed to acquire Astria Therapeutics, Inc.. - MarketScreener

11:50 AM

11:38 AM

BioCryst goes ‘all in’ on rare swelling disease with Astria deal - BioPharma Dive

11:38 AM

11:21 AM

Here’s Why Astria Therapeutics Stock (ATXS) Exploded Today - TipRanks

11:21 AM

11:17 AM

BioCryst to Acquire Astria Therapeutics in $700 Million Deal - Contract Pharma

11:17 AM

10:52 AM

BioCryst deepens rare diseases focus with $700 million deal for Astria - Reuters

10:52 AM

09:53 AM

BioCryst To Acquire Astria Therapeutics - citybiz

09:53 AM

09:36 AM

Mergers and acquisitions - TradingView

09:36 AM

08:59 AM

Is the Options Market Predicting a Spike in BioCryst Pharmaceuticals Stock? - Yahoo Finance

08:59 AM

08:29 AM

ATXS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Astria Therapeutics, Inc. Is Fair to Shareholders - Business Wire

08:29 AM

08:07 AM

BioCryst to Acquire Astria Therapeutics for $700 Million Includi - GuruFocus

08:07 AM

08:06 AM

BioCryst Announces Acquisition of Astria Therapeutics (ATXS) at $13.00 Per Share - GuruFocus

08:06 AM

08:04 AM

BioCryst (BCRX) to Acquire Astria Therapeutics in $700M Deal - GuruFocus

08:04 AM

08:02 AM

BioCryst To Acquire Astria Therapeutics In $700M Deal - Stocktwits

08:02 AM

08:00 AM

BioCryst Pharmaceuticals To Acquire Astria Therapeutics In $700 Million Cash-and-Stock Deal - Nasdaq

08:00 AM

07:58 AM

BioCryst to acquire Astria Therapeutics for $700 million - Investing.com

07:58 AM

07:56 AM

BioCryst to acquire Astria Therapeutics for $700 million By Investing.com - Investing.com Canada

07:56 AM

07:50 AM

BioCryst to Acquire Astria in Deal Valued at $700 Million - MarketScreener

07:50 AM

07:48 AM

BioCryst to buy Astria Therapeutics in $700 million deal - Yahoo Finance

07:48 AM

07:37 AM

BioCryst To Acquire Astria Therapeutics In $700 Mln Cash-and-Stock Deal - Nasdaq

07:37 AM

07:33 AM

Astria Therapeutics stock soars after BioCryst acquisition announcement, BioCryst falls By Investing.com - Investing.com Canada

07:33 AM

07:32 AM

BioCryst Announces Merger with Astria Therapeutics - TipRanks

07:32 AM

07:31 AM

BioCryst to buy Astria Therapeutics for $13 per share - MSN

07:31 AM

07:15 AM

BioCryst Pharmaceuticals Appoints New Board Member - TradingView

07:15 AM

07:13 AM

BioCryst Pharmaceuticals to Acquire Astria Therapeutics, Expanding HAE Portfolio with Navenibart in $920 Million Deal - Quiver Quantitative

07:13 AM

07:04 AM

BioCryst to Acquire Astria Therapeutics, Strengthening Presence in HAE, Transforming Growth Profile - GlobeNewswire

07:04 AM

Oct 13, 2025

BioCryst Pharmaceuticals To Acquire Astria In $700 Million Deal - Finimize

Oct 13, 2025

Oct 13, 2025

Orion, Nuburu, And BioCryst Shares All Tumble On Bad News - Finimize

Oct 13, 2025

Oct 13, 2025

BioCryst's Orladeyo up for FDA review in pediatric HAE patients - MSN

Oct 13, 2025

Oct 13, 2025

Why retail investors pile into BioCryst Pharmaceuticals Inc. stockWeekly Stock Analysis & AI Based Buy/Sell Signal Reports - newser.com

Oct 13, 2025

Oct 13, 2025

Applying sector rotation models to BioCryst Pharmaceuticals Inc.Quarterly Investment Review & Long-Term Safe Return Strategies - newser.com

Oct 13, 2025

Oct 13, 2025

Quantitative breakdown of BioCryst Pharmaceuticals Inc. recent move2025 Dividend Review & Community Consensus Trade Signals - newser.com

Oct 13, 2025

Oct 12, 2025

BioCryst Bets Big On Rare Disease With ORLADEYO’s Growth - Finimize

Oct 12, 2025

Oct 10, 2025

Will Analyst Optimism Shift BioCryst’s (BCRX) Narrative Beyond Its Single-Drug Reliance? - Sahm

Oct 10, 2025

Oct 10, 2025

How high can BioCryst Pharmaceuticals Inc. stock goAnalyst Downgrade & Fast Entry High Yield Stock Tips - newser.com

Oct 10, 2025

Oct 10, 2025

Multi factor analysis applied to BioCryst Pharmaceuticals Inc.Earnings Performance Report & AI Driven Stock Movement Reports - newser.com

Oct 10, 2025

Oct 10, 2025

How BioCryst Pharmaceuticals Inc. stock reacts to oil pricesAnalyst Upgrade & Proven Capital Preservation Tips - newser.com

Oct 10, 2025

Oct 09, 2025

Weiss Ratings Reiterates "Sell (D-)" Rating for BioCryst Pharmaceuticals (NASDAQ:BCRX) - MarketBeat

Oct 09, 2025

Oct 09, 2025

RBC Capital Sticks to Their Buy Rating for BioCryst (BCRX) - The Globe and Mail

Oct 09, 2025